Oncolytics Biotech
ONCY
#9647
Rank
โ‚น9.53 B
Marketcap
โ‚น79.89
Share price
-3.60%
Change (1 day)
-25.43%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of March 2026 : โ‚น0.53 Billion

According to Oncolytics Biotech 's latest financial reports the company has โ‚น0.53 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚น0.46 B-50.87%
2024-12-31โ‚น0.95 B-56.62%
2023-12-31โ‚น2.19 B11.81%
2022-12-31โ‚น1.95 B-18.65%
2021-12-31โ‚น2.40 B34.53%
2020-12-31โ‚น1.79 B131.83%
2019-12-31โ‚น0.77 B9.82%
2018-12-31โ‚น0.70 B17.03%
2017-12-31โ‚น0.60 B-15.83%
2016-12-31โ‚น0.71 B-42.82%
2015-12-31โ‚น1.24 B41.33%
2014-12-31โ‚น0.88 B-44.06%
2013-12-31โ‚น1.57 B34.78%
2012-12-31โ‚น1.17 B-35.11%
2011-12-31โ‚น1.80 B-6.05%
2010-12-31โ‚น1.92 B27.11%
2009-12-31โ‚น1.51 B188.42%
2008-12-31โ‚น0.52 B-47.52%
2007-12-31โ‚น0.99 B-4.77%
2006-12-31โ‚น1.04 B-32.98%
2005-12-31โ‚น1.56 B28.12%
2004-12-31โ‚น1.22 B67.71%
2003-12-31โ‚น0.72 B187.53%
2002-12-31โ‚น0.25 B-44.15%
2001-12-31โ‚น0.45 B-17.26%
2000-12-31โ‚น0.54 B301.61%
1999-12-31โ‚น0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eli Lilly
LLY
โ‚น509.91 B 96,058.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.012 T 190,797.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
โ‚น94.26 B 17,675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
โ‚น2.68 B 406.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น361.14 B 68,004.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
โ‚น7.47 B 1,309.03%๐Ÿ‡บ๐Ÿ‡ธ USA